Selection and verification of antibodies against the cytoplasmic domain of M2 of influenza, a transmembrane protein

References

• Alberts B, Johnson A, Lewis J, Alberts B, et al. MeMolecular biology of the cell. 4th. Garland Science; https://www.ncbi.nlm.nih.gov/books/NBK26878/
   Google Scholar
• Wegener KL, Campbell ID. Transmembrane and cytoplasmic domains in integrin activation and protein-protein interactions (Review). Mol Membr Biol. 2008;25(5):376–10. doi:https://doi.org/10.1080/09687680802269886.
   PubMed Web of Science ®Google Scholar
• Postler TS, Desrosiers RC. The Tale of the Long Tail: the Cytoplasmic Domain of HIV-1 gp41. J Virol. 2013;87(1):2–15. doi:https://doi.org/10.1128/JVI.02053-12.
   PubMedGoogle Scholar
• White JM, Delos SE, Brecher M, Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol. 2008;43(3):189–219. doi:https://doi.org/10.1080/10409230802058320.
   PubMed Web of Science ®Google Scholar
• Schnell JR, Chou JJ. Structure and mechanism of the M2 proton channel of influenza A virus. Nature. 2008;451(7178):591–95. doi:https://doi.org/10.1038/nature06531.
   PubMed Web of Science ®Google Scholar
• Cady SD, Luo W, Hu F, Hong M. Structure and function of the Influenza A M2 proton channel. Biochemistry. 2009;48(31):7356–64. doi:https://doi.org/10.1021/bi9008837.
   PubMedGoogle Scholar
• McCown MF, Pekosz A. Distinct domains of the Influenza A virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. J Virol. 2006;80(16):8178–89. doi:https://doi.org/10.1128/JVI.00627-06.
   PubMedGoogle Scholar
• Beale R, Wise H, Stuart A, Ravenhill BJ, Digard P, Randow F. A LC3-Interacting Motif in the Influenza A virus M2 protein is required to subvert autophagy and maintain virion stability. Cell Host Microbe. 2014;15(2):239–47. doi:https://doi.org/10.1016/j.chom.2014.01.006.
   PubMed Web of Science ®Google Scholar
• Bradbury A, Plückthun A. Reproducibility: standardize antibodies used in research. Nature. 2015;518(7537):27–29. doi:https://doi.org/10.1038/518027a.
   PubMed Web of Science ®Google Scholar
• Bradbury ARM, Plückthun A. Getting to reproducible antibodies: the rationale for sequenced recombinant characterized reagents. Protein Eng Des Sel. 2015;28(10):303–05. doi:https://doi.org/10.1093/protein/gzv051.
   PubMed Web of Science ®Google Scholar
• Bradbury ARM, Trinklein ND, Thie H, Wilkinson IC, Tandon AK, Anderson S, Bladen CL, Jones B, Aldred SF, Bestagno M, et al. When monoclonal antibodies are not monospecific: hybridomas frequently express additional functional variable regions. mAbs. 2018;10(4):539–46. doi:https://doi.org/10.1080/19420862.2018.1445456.
   PubMed Web of Science ®Google Scholar
• Bradbury AM, Plückthun A. Antibodies: validate recombinants once. Nature. 2015;520(7547):295–295. doi:https://doi.org/10.1038/520295b.
   PubMed Web of Science ®Google Scholar
• Bradbury ARM, Sidhu S, Dübel S, McCafferty J. Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol. 2011;29:245.
   PubMed Web of Science ®Google Scholar
• Velappan N, Mahajan A, Naranjo L, Velappan P, Andrews N, Tiee N, Chakraborti S, Hemez C, Gaiotto T, Wilson B, et al. Selection and characterization of FcεRI phospho-ITAM specific antibodies. mAbs. 2019;11(7):1206–18. doi:https://doi.org/10.1080/19420862.2019.1632113.
   PubMed Web of Science ®Google Scholar
• Gabbard J, Velappan N, Di Niro R, Schmidt J, Jones CA, Tompkins SM, Bradbury ARM. A humanized anti-M2 scFv shows protective in vitro activity against influenza. Protein Eng Des Sel. 2008;22(3):189–98. doi:https://doi.org/10.1093/protein/gzn070.
   PubMedGoogle Scholar
• Sblattero D, Bradbury A. Exploiting recombination in single bacteria to make large phage antibody libraries. Nat Biotechnol. 2000;18(1):75–80. doi:https://doi.org/10.1038/71958.
   PubMed Web of Science ®Google Scholar
• Ferrara F, Naranjo LA, Kumar S, Gaiotto T, Mukundan H, Swanson B, Bradbury ARM. Lenz LL. Using phage and yeast display to select hundreds of monoclonal antibodies: application to antigen 85, a tuberculosis biomarker. PLoS ONE. 2012;7(11):e49535. doi:https://doi.org/10.1371/journal.pone.0049535.
   PubMed Web of Science ®Google Scholar
• Markiv A, Beatson R, Burchell J, Durvasula RV, Kang AS. Expression of recombinant multi-coloured fluorescent antibodies in gor−/trxB− E. coli cytoplasm. BMC Biotechnol. 2011;11(1):117. doi:https://doi.org/10.1186/1472-6750-11-117.
   PubMedGoogle Scholar
• Markiv A, Anani B, Durvasula RV, Kang AS. Module based antibody engineering: A novel synthetic REDantibody. J Immunol Methods. 2011;364(1–2):40–49. doi:https://doi.org/10.1016/j.jim.2010.10.009.
   PubMedGoogle Scholar
• Naranjo L, Ferrara F, Blanchard N, Demangel C, D’Angelo S, Erasmus MF, Teixera AA, Bradbury ARM. Recombinant Antibodies against Mycolactone. Toxins. 2019;11(6):346. doi:https://doi.org/10.3390/toxins11060346.
   Google Scholar
• Wang R, Song A, Levin J, DENNIS D, ZHANG N, YOSHIDA H, KORIAZOVA L, MADURA L, SHAPIRO L, MATSUMOTO A, et al. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein. Antiviral Res. 2008;80(2):168–77. doi:https://doi.org/10.1016/j.antiviral.2008.06.002.
   PubMed Web of Science ®Google Scholar
• Lee SC, Knowles TJ, Postis VLG, Jamshad M, Parslow RA, Lin Y-P, Goldman A, Sridhar P, Overduin M, Muench SP, et al. A method for detergent-free isolation of membrane proteins in their local lipid environment. Nat Protoc. 2016;11(7):1149–62. doi:https://doi.org/10.1038/nprot.2016.070.
   PubMedGoogle Scholar
• Lillo AM, Ayriss JE, Shou Y, Graves SW, Bradbury ARM. Development of Phage-Based Single Chain Fv Antibody Reagents for Detection of Yersinia pestis. PLOS ONE. 2011;6(12):e27756. doi:https://doi.org/10.1371/journal.pone.0027756
   Google Scholar
• Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R. Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov. 2018;17(1):35–56. doi:https://doi.org/10.1038/nrd.2017.162.
   PubMed Web of Science ®Google Scholar
• Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469(7330):323–35. doi:https://doi.org/10.1038/nature09782.
   PubMed Web of Science ®Google Scholar
• Gannagé M, Dormann D, Albrecht R, Dengjel J, Torossi T, Rämer PC, Lee M, Strowig T, Arrey F, Conenello G, et al. Matrix protein 2 of Influenza a virus blocks autophagosome fusion with lysosomes. Cell Host Microbe. 2009;6(4):367–80. doi:https://doi.org/10.1016/j.chom.2009.09.005.
   PubMed Web of Science ®Google Scholar
• Dumit VI, Dengjel J. Autophagosomal protein dynamics and influenza virus infection. Front Immunol. 2012:3. doi:https://doi.org/10.3389/fimmu.2012.00043.
   Google Scholar
• J-D P, Cabantous S, Tran T, Terwilliger TC, Waldo GS. Engineering and characterization of a superfolder green fluorescent protein. Nat Biotechnol. 2006;24(1):79–88. doi:https://doi.org/10.1038/nbt1172.
   PubMedGoogle Scholar
• Kapust RB, Tözsér J, Copeland TD, Waugh DS. The P1′ specificity of tobacco etch virus protease. Biochem Biophys Res Commun. 2002;294(5):949–55. doi:https://doi.org/10.1016/S0006-291X(02)00574-0.
   PubMed Web of Science ®Google Scholar
• Kiss C, Fisher H, Pesavento E, Dai M, Valero R, Ovecka M, Nolan R, Phipps ML, Velappan N, Chasteen L, et al. Antibody binding loop insertions as diversity elements. Nucleic Acids Res. 2006;34(19):e132–e132. doi:https://doi.org/10.1093/nar/gkl681.
   PubMedGoogle Scholar
• Reed LJ, Muench H. A Simple method of estimating fifty per cent endpoints 12. Am J Epidemiol. 1938;27(3):493–97. doi:https://doi.org/10.1093/oxfordjournals.aje.a118408.
   Google Scholar